Twice-weekly aripiprazole for treating children and adolescents with tic disorder, a randomized controlled clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201312263930N32

Enrollment

Registered

2014-08-03

Start date

2014-01-13

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tic disorder. Tic disorders

Interventions

Intervention 1: aripiprazole up to 10 mg/day every day. Intervention 2: aripiprazole up to 10 mg/day every two times per week.

Treatment - Drugs

aripiprazole up to 10 mg/day every day

aripiprazole up to 10 mg/day every two times per week

Eligibility

Sex/Gender

All

Age

5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: children and adolescents aged 5 to 18 years; total score of YGTS more than 21. Exclusion criteria: Marked general medical condition; hypersensitivity to the medications.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Tic severity. Timepoint: Every 4 weeks. Method of measurement: Yale global tic severity scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Ghanizadeh

Shiraz University of Medical sciences

ghanizad@sina.tums.ac.ir+98 71 1627 3070

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 1, 2026